Mostrando 4 resultados de: 4
Filtros aplicados
Publisher
2007 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2007, Technical Proceedings(2)
ChemMedChem(1)
Nano Today(1)
Área temáticas
Farmacología y terapéutica(4)
Enfermedades(3)
Ingeniería y operaciones afines(2)
Medicina y salud(1)
Química analítica(1)
Origen
scopus(4)
Co-delivery of hydrophobic and hydrophilic drugsfrom nanoparticle-aptamer bioconjugates
ArticleAbstract: (Figure Presented) Herein we report a novel targeted drug delivery system consisting of nanoparticlePalabras claves:Antitumor agents, conjugation, Dual drug delivery, Nanoparticles, Targeted therapyAutores:Bagalkot V., Basto P.A., Farokhzad O.C., Frank Alexis, Gu F.X., Jon S., Langer R.S., Radovic-Moreno A.F., Zhang L.Fuentes:scopusTargeted aptamer-nanoparticles to diminish drug resistance of cancer cells in vitro study
Conference ObjectAbstract: Using prostate cancer as a model, we report the drug release of Docetaxel and doxorubicin from aptamPalabras claves:aptamer, doxorubicin, Poly (D,L-lactic-co-glycolic acid) (PLGA), Prostate cancer, Targeted deliveryAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Langer R.S., Zhang L.Fuentes:scopusTargeted nanoparticle-polypeptide bioconjugates for breast cancer therapy
Conference ObjectAbstract: Novel approaches that allow for a more effective and less toxic chemotherapy for disseminated breastPalabras claves:Docetaxel, HER2, Pla, Poly (lactic acid), Targeted nanoparticlesAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Gu F.X., Langer R.S., Levy-Nissenbaum E., Radovic-Moreno A.F.Fuentes:scopusTargeted nanoparticles for cancer therapy
ArticleAbstract: Over the past decade, there has been an increasing interest in using nanotechnology for cancer theraPalabras claves:Autores:Farokhzad O.C., Frank Alexis, Gu F.X., Hong S., Karnik R., Langer R.S., Levy-Nissenbaum E., Wang A.Z.Fuentes:scopus